Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplants can temporarily help with eyebrow hair loss.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

The Brigham Eyebrow Tool for Alopecia is a simple and reliable way to measure eyebrow hair loss.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Alopecia Areata patients have too many Firmicutes and too few Bacteroides in their gut.

Etanercept may not prevent alopecia areata from coming back.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Injecting vitamin D3 into the skin is an effective treatment for patchy hair loss.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

The treatment is a safe and effective option for hair regrowth in patchy alopecia areata.

General practitioners in Qassim have satisfactory knowledge of alopecia areata but need more education to address gaps and misconceptions.

People with autism are more likely to develop alopecia areata than those without autism.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

The study concluded that short vellus hair and yellow dots were the most common signs of alopecia areata, indicating disease activity and remission.

Topical tofacitinib is effective and safe for treating alopecia areata.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Granulomatous alopecia areata is a rare but real form of hair loss.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Differences in skin and gut bacteria may contribute to alopecia areata.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Hair loss from alopecia areata and androgenetic alopecia moderately affects the quality of life, especially in younger patients and those with long-term hair loss, impacting both their physical and emotional well-being.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.